Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Raouf Ben-Abdelali"'
Autor:
Marie Sebert, Stéphanie Gachet, Thierry Leblanc, Alix Rousseau, Olivier Bluteau, Rathana Kim, Raouf Ben Abdelali, Flore Sicre de Fontbrune, Loïc Maillard, Carèle Fedronie, Valentine Murigneux, Léa Bellenger, Naira Naouar, Samuel Quentin, Lucie Hernandez, Nadia Vasquez, Mélanie Da Costa, Pedro H. Prata, Lise Larcher, Marie de Tersant, Matthieu Duchmann, Anna Raimbault, Franck Trimoreau, Odile Fenneteau, Wendy Cuccuini, Nathalie Gachard, Nathalie Auger, Giulia Tueur, Maud Blanluet, Claude Gazin, Michèle Souyri, Francina Langa Vives, Aaron Mendez-Bermudez, Hélène Lapillonne, Etienne Lengline, Emmanuel Raffoux, Pierre Fenaux, Lionel Adès, Edouard Forcade, Charlotte Jubert, Carine Domenech, Marion Strullu, Bénédicte Bruno, Nimrod Buchbinder, Caroline Thomas, Arnaud Petit, Guy Leverger, Gérard Michel, Marina Cavazzana, Eliane Gluckman, Yves Bertrand, Nicolas Boissel, André Baruchel, Jean-Hugues Dalle, Emmanuelle Clappier, Eric Gilson, Ludovic Deriano, Sylvie Chevret, François Sigaux, Gérard Socié, Dominique Stoppa-Lyonnet, Hugues de Thé, Christophe Antoniewski, Dominique Bluteau, Régis Peffault de Latour, Jean Soulier
Publikováno v:
Cell Stem Cell
Cell Stem Cell, 2023, 30 (2), pp.153-170.e9. ⟨10.1016/j.stem.2023.01.006⟩
Cell Stem Cell, 2023, 30 (2), pp.153-170.e9. ⟨10.1016/j.stem.2023.01.006⟩
International audience; Fanconi anemia (FA) patients experience chromosome instability, yielding hematopoietic stem/progenitor cell (HSPC) exhaustion and predisposition to poor-prognosis myeloid leukemia. Based on a longitudinal cohort of 335 patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c04c73d99e0cccd9d3216befe9e7cea
https://hal.science/hal-04157812
https://hal.science/hal-04157812
Autor:
Lucas Ramon, Catherine David, Karine Fontaine, Elodie Lallet, Charles Marcaillou, Séverine Martin-Lannerée, Virginie Decaulne, Céline Vazart, Anne-Héloise Gélibert, Raouf Ben Abdelali, Jean-Marc Costa, Francis Rousseau, Raphaële Thiébaut, Larry Yost, Yann Gaston-Mathé
Publikováno v:
Biomarker Insights, Vol 13 (2018)
MiR-31-3p expression has been shown to be a predictive biomarker for response to anti-epithelial growth factor receptor therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC). To aid in the quantification of miR-31-3p expression i
Externí odkaz:
https://doaj.org/article/29d467dfb55d46a394e871291f5aab64
Autor:
Jean-Edouard Martin, Christine Bellanné-Chantelot, Olivier Caron, Pascal Fuseau, Nathalie Auger, Barbara Schmaltz-Panneau, Sophie Cotteret, Stéphane de Botton, Christophe Willekens, Florence Pasquier, Christophe Marzac, Jean-Baptiste Micol, Jean Pegliasco, Maureen Lopez, William Vainchenker, Adel Ben-Ali, Véronique Saada, Carole Bourdin, Flore Salviat, Odile Bera, Sabine Khalife-Hachem, Isabelle Plo, Cristina Castilla-Llorent, Philippe Helias, Jean-Côme Meniane, Samy Chraibi, Raouf Ben-Abdelali
Publikováno v:
Leukemia & Lymphoma. 62:1770-1773
Genetic predisposition to acute myeloid leukemia (AML) concerns a minority of adult patients. Development of high-throughput sequencing technologies over the last ten years allowed identification o...
Autor:
Sylvain Thépot, Raouf Ben Abdelali, Sylvie Chevret, Aline Renneville, Odile Beyne-Rauzy, Thomas Prébet, Sophie Park, Aspasia Stamatoullas, Agnes Guerci-Bresler, Stéphane Cheze, Gérard Tertian, Bachra Choufi, Laurence Legros, Jean Noel Bastié, Jacques Delaunay, Marie Pierre Chaury, Laurence Sanhes, Eric Wattel, Francois Dreyfus, Norbert Vey, Fatiha Chermat, Claude Preudhomme, Pierre Fenaux, Claude Gardin
Publikováno v:
Haematologica, Vol 101, Iss 8 (2016)
The efficacy of azacitidine in patients with anemia and with lower-risk myelodysplastic syndromes, if relapsing after or resistant to erythropoietic stimulating agents, and the benefit of combining these agents to azacitidine in this setting are not
Externí odkaz:
https://doaj.org/article/dcc821d2ee5a454fb0d4fe2816dcf54e
Autor:
Pierre Peterlin, Aline Renneville, Raouf Ben Abdelali, Olivier Nibourel, Xavier Thomas, Cécile Pautas, Stéphane de Botton, Emmanuel Raffoux, Jean-Michel Cayuela, Nicolas Boissel, Christine Terré, Karine Celli-Lebras, Sylvie Castaigne, Claude Preudhomme, Claude Gardin, Hervé Dombret
Publikováno v:
Haematologica, Vol 100, Iss 5 (2015)
Externí odkaz:
https://doaj.org/article/75d7695f921847e98f8750f51878b5f6
Autor:
Raouf Ben Abdelali, Vahid Asnafi, Arnaud Petit, Jean-Baptiste Micol, Céline Callens, Patrick Villarese, Eric Delabesse, Oumedaly Reman, Stephane Lepretre, Jean-Yves Cahn, Gaelle Guillerm, Céline Berthon, Claude Gardin, Bernadette Corront, Thibaut Leguay, Marie-Christine Béné, Norbert Ifrah, Guy Leverger, Hervé Dombret, Elizabeth Macintyre
Publikováno v:
Haematologica, Vol 98, Iss 11 (2013)
CALM-AF10 (also known as PICALM-MLLT10) is the commonest fusion protein in T-cell acute lymphoblastic leukemia, but its prognostic impact remains unclear. Molecular screening at diagnosis identified CALM-AF10 in 30/431 (7%) patients with T-cell acute
Externí odkaz:
https://doaj.org/article/47f28ed02797482a8a58fe70e9f38362
Autor:
Jean-Claude Chomel, Jean-Christophe Ianotto, Laurane Cottin, Pierre Sujobert, Véronique Mansat-De Mas, Barbara Burroni, Vincent Cussac, Nathalie Jézéquel, Brigitte Dupriez, Bruno Cassinat, Emmanuelle Verger, Raouf Ben Abdelali, Dana Ranta, Damien Luque Paz, Olivier Kosmider, Olivier Mansier, Gabriel Etienne, Jerome Rey, Maxime Renard, Jean-Jacques Kiladjian, Fabienne Vacheret, Guillaume Denis, Anne Murati, Jérémie Riou, Pascal Mossuz, Françoise Boyer, Eric Lippert, Yannick Le Bris, Pascale Cony-Makhoul, Ivan Sloma, Anouk Walter-Petrich, Suzanne Tavitian, Stéphane Giraudier, Stéphane Girault, Aurélie Chauveau, Gérard Socié, François Girodon, Lydia Roy, Olivier Nibourel, Borhane Slama, Valérie Ugo, Margot Robles, Mathieu Wemeau
Publikováno v:
Blood Advances
Blood Advances, 2021, 5, pp.1442-1451. ⟨10.1182/bloodadvances.2020003444⟩
Blood Advances, The American Society of Hematology, 2021, 5, pp.1442-1451. ⟨10.1182/bloodadvances.2020003444⟩
Blood Adv
Blood Advances, 2021, 5, pp.1442-1451. ⟨10.1182/bloodadvances.2020003444⟩
Blood Advances, The American Society of Hematology, 2021, 5, pp.1442-1451. ⟨10.1182/bloodadvances.2020003444⟩
Blood Adv
We aimed to study the prognostic impact of the mutational landscape in primary and secondary myelofibrosis. The study included 479 patients with myelofibrosis recruited from 24 French Intergroup of Myeloproliferative Neoplasms (FIM) centers. The mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c8940c1350fb349d712d80d7c3b70f5
https://www.hal.inserm.fr/inserm-03187575/document
https://www.hal.inserm.fr/inserm-03187575/document
Autor:
Jean-Michel Cayuela, Elizabeth Macintyre, Meryl Darlington, Raouf Ben Abdelali, Xavier Fund, Patrick Villarese, Michel Tulliez, Emmanuel Raffoux, François Sigaux, Delphine Réa, Valerie Seror
Publikováno v:
Haematologica, Vol 96, Iss 5 (2011)
Background Molecular monitoring of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors is essential for therapeutic stratification. Inter-laboratory reproducibility is, therefore, a crucial issue which requires standardization a
Externí odkaz:
https://doaj.org/article/6f40d7b9645941f89e76bee106e5e28e
Autor:
Agnès Paquet, Olivier Nibourel, Soizic Guihard, C Demay, Claude Preudhomme, Karine Celli-Lebras, Pauline Peyrouze, Jean Soulier, Christophe Roumier, Aline Renneville, Raouf Ben Abdelali, Pascal Barbry, Antonio José Alberdi, Sylvie Castaigne, Christine Terré, Nicolas Pottier, Hervé Dombret, Sandrine Geffroy, Samuel Quentin, Meyling Cheok, Bruno Quesnel
Publikováno v:
Leukemia. 31:555-564
Recent advances in genomic technologies have revolutionized acute myeloid leukemia (AML) understanding by identifying potential novel actionable genomic alterations. Consequently, current risk stratification at diagnosis not only relies on cytogeneti
Autor:
Sylvie Chevret, Fatiha Chermat, Pierre Fenaux, Sophie Park, jean Noel Bastie, François Dreyfus, Raouf Ben Abdelali, Claude Preudhomme, Aline Renneville, Jacques Delaunay, Thomas Prebet, Stéphane Cheze, Claude Gardin, Bachra Choufi, Gérard Tertian, Sylvain Thepot, Odile Beyne-Rauzy, Eric Wattel, Marie Pierre Chaury, Norbert Vey, Laurence Legros, Laurence Sanhes, Agnès Guerci-Bresler, Aspasia Stamatoullas
Publikováno v:
Haematologica. 101:918-925
The efficacy of azacitidine in patients with anemia and with lower-risk myelodysplastic syndromes, if relapsing after or resistant to erythropoietic stimulating agents, and the benefit of combining these agents to azacitidine in this setting are not